Isolation of ferritin from human hepatocellular carcinoma.
Ferritin was extracted from human hepatocellular carcinoma tissue and purified using column chromatography, gradient gel electrophoresis and cadmium sulphate crystallization. DEAE cellulose chromatography showed a difference between hepatoma and normal liver ferritin, indicative of a more acidic isoferritin profile in the tumour. Column-purified and crystalline ferritin and that remaining in the mother-liquor after crystallization was subjected to isoelectric focusing. Hepatoma ferritin showed higher concentrations of acidic isoferritins than liver ferritin. This was most obvious with mother-liquor ferritin, as crystallization tended to select out more basic isoferritins. Subunit analysis of hepatoma and liver ferritin showed a higher proportion of heavy subunits in the tumour ferritin, in keeping with the presence of acidic isoferritins. An antibody against hepatoma mother-liquor ferritin was raised in rabbits. However, hepatoma ferritin proved to be antigenically identical with normal liver ferritin, and we were thus unable to develop a specific radioimmunoassay for hepatoma ferritin.
D006528:Carcinoma, Hepatocellular / Q000032:analysis*; D005293:Ferritins / Q000302:isolation & purification*; D006801:Humans; D005779:Immunodiffusion; D007501:Iron / Q000032:analysis; D007525:Isoelectric Focusing; D008099:Liver / Q000032:analysis; D008113:Liver Neoplasms / Q000032:analysis*; D046911:Macromolecular Substances; D011863:Radioimmunoassay
D046911:Macromolecular Substances; D005293:Ferritins; D007501:Iron